![Jennifer Herron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Herron
Directeur/Membre du Conseil chez
Gwynedd-Mercy Academy
Profil
Jennifer L.
Herron is a Trustee at Gwynedd-Mercy Academy.
She previously worked as an Independent Director at ChemoCentryx, Inc. and Genocea Biosciences, Inc. She was also the Vice President-US Immunology at Bristol Myers Squibb Co. from 2006 to 2016.
In addition, she served as the Chief Commercial Officer & Executive Vice President at ImmunoGen, Inc. in 2019, and as the President & Executive VP-Global Commercial at MorphoSys AG and Bio-Rad AbD Serotec, Inc. She started her career as an Associate at Boehringer Mannheim Pharmaceuticals Corp.
Ms. Herron's education includes an undergraduate degree from Lehigh University and an MBA from Georgetown University.
Currently, she is a Trustee at Gwynedd-Mercy Academy and the Chief Commercial Officer & Senior Vice President at ADC Therapeutics SA.
Postes actifs de Jennifer Herron
| Sociétés | Poste | Début |
|---|---|---|
Gwynedd-Mercy Academy
 Gwynedd-Mercy Academy Other Consumer ServicesConsumer Services Operates as secondary school | Directeur/Membre du Conseil | - |
Anciens postes connus de Jennifer Herron
| Sociétés | Poste | Fin |
|---|---|---|
| ADC THERAPEUTICS SA | Corporate Officer/Principal | 17/11/2022 |
| CHEMOCENTRYX, INC. | Directeur/Membre du Conseil | 20/10/2022 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 01/03/2019 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2016 |
Formation de Jennifer Herron
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Bio-Rad AbD Serotec, Inc.
 Bio-Rad AbD Serotec, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies monoclonal and polyclonal antibodies to the research community | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Mannheim Pharmaceuticals Corp. | |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Gwynedd-Mercy Academy
Gwynedd-Mercy Academy Other Consumer ServicesConsumer Services Operates as secondary school | Consumer Services |
